{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:15:47Z","timestamp":1778681747600,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI088654"],"award-info":[{"award-number":["U01AI088654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K02TW009483"],"award-info":[{"award-number":["K02TW009483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.036","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T10:31:36Z","timestamp":1507026696000},"page":"6202-6207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015"],"prefix":"10.1016","volume":"35","author":[{"given":"Sophia","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saira","family":"Saborio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermina","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Gresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nery","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubree","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.036_b0005","doi-asserted-by":"crossref","first-page":"e2024","DOI":"10.1097\/MD.0000000000002024","article-title":"Hospitalization incidence, mortality, and seasonality of common respiratory viruses over a period of 15 years in a developed subtropical city","volume":"94","author":"Chan","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2017.09.036_b0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12889-016-3128-4","article-title":"Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom","volume":"16","author":"Matias","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2017.09.036_b0015","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.09.036_b0020","unstructured":"Centers for Disease Control and Prevention (CDC). Weekly U.S. Influenza Surveillance Report. FluView 2016."},{"key":"10.1016\/j.vaccine.2017.09.036_b0025","unstructured":"Hong Kong Centre for Health Protection. Local Situation of Influenza Activity (as of Jul 27, 2016). Flu Express 2016;13."},{"key":"10.1016\/j.vaccine.2017.09.036_b0030","doi-asserted-by":"crossref","first-page":"e1005526","DOI":"10.1371\/journal.ppat.1005526","article-title":"Identification of low- and high-impact hemagglutinin amino acid substitutions that drive antigenic drift of influenza A(H1N1) viruses","volume":"12","author":"Harvey","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.09.036_b0035","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1073\/pnas.1409171111","article-title":"Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013\u20132014 influenza season","volume":"111","author":"Linderman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.09.036_b0040","first-page":"483","article-title":"Influenza activity \u2013 United States, 2013\u201314 season and composition of the 2014\u201315 influenza vaccines","volume":"63","author":"Epperson","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.09.036_b0045","doi-asserted-by":"crossref","first-page":"e0118884","DOI":"10.1371\/journal.pone.0118884","article-title":"Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009\u20132013","volume":"10","author":"Cohen","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.09.036_b0050","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season 2016."},{"key":"10.1016\/j.vaccine.2017.09.036_b0055","article-title":"Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014","volume":"19","author":"Turner","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2017.09.036_b0060","article-title":"Interim estimates of 2013\/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014","volume":"19","author":"Skowronski","year":"2014","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"10.1016\/j.vaccine.2017.09.036_b0065","first-page":"10","article-title":"Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses","author":"Tewawong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.09.036_b0070","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/infdis\/jiw479","article-title":"Antibodies against the current influenza A(H1N1) vaccine strain do not protect some individuals from infection with contemporary circulating influenza A(H1N1) virus strains","volume":"214","author":"Petrie","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0075","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/652647","article-title":"Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua","volume":"50","author":"Gordon","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/INF.0000000000000944","article-title":"Burden of influenza and influenza-associated pneumonia in the first year of life in a prospective cohort study in Managua, Nicaragua","volume":"35","author":"Gresh","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.036_b0085","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3201\/eid1503.080238","article-title":"Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005\u20132007","volume":"15","author":"Gordon","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12879-015-1256-6","article-title":"The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance","volume":"15","author":"Gordon","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/INF.0000000000001083","article-title":"The Timeline of influenza virus shedding in children and adults in a household transmission study of influenza in Managua, Nicaragua","volume":"35","author":"Ng","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.09.036_b0100","doi-asserted-by":"crossref","unstructured":"Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605\u201315. https:\/\/doi.org\/10.1056\/NEJMoa0903810.","DOI":"10.1056\/NEJMoa0903810"},{"key":"10.1016\/j.vaccine.2017.09.036_b0105","unstructured":"WHO Global Influenza. Manual for the laboratory diagnosis and virological surveillance of influenza; 2011."},{"key":"10.1016\/j.vaccine.2017.09.036_b0110","unstructured":"Chambers JM, Hastie T. Statistical models in S. Pacific Grove, Calif.: Wadsworth & Brooks\/Cole Advanced Books & Software; 1992."},{"key":"10.1016\/j.vaccine.2017.09.036_b0115","series-title":"Handbook of structural equation modeling","author":"Hoyle","year":"2012"},{"key":"10.1016\/j.vaccine.2017.09.036_b0120","doi-asserted-by":"crossref","first-page":"30168","DOI":"10.2807\/1560-7917.ES.2016.21.11.30168","article-title":"Interim estimates of 2015\/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016","volume":"21","author":"Chambers","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2017.09.036_b0125","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1017\/S0950268816000819","article-title":"Pooled influenza vaccine effectiveness estimates for Australia, 2012\u20132014","volume":"144","author":"Sullivan","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.09.036_b0130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0135","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2017.09.036_b0140","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.vaccine.2015.11.058","article-title":"The confounded effects of age and exposure history in response to influenza vaccination","volume":"34","author":"Moster\u00edn H\u00f6pping","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.036_b0145","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.09.036_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2017.09.036_b0155","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.036_b0160","doi-asserted-by":"crossref","first-page":"e25848","DOI":"10.1371\/journal.pone.0025848","article-title":"Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties","volume":"6","author":"Strengell","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.09.036_b0165","first-page":"5","article-title":"Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses","author":"Medina","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.09.036_b0170","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1128\/JVI.02962-14","article-title":"Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses","volume":"89","author":"Koel","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.09.036_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw479","article-title":"Antibodies against the current influenza A H1N1 vaccine strain do not protect some individuals from infection with contemporary circulating H1N1 viral strains","author":"Petrie","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.036_b0180","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.115.2.434","article-title":"Host defenses against influenza virus: the role of anti-hemagglutinin antibody","volume":"115","author":"Virelizier","year":"1975","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.09.036_b0185","doi-asserted-by":"crossref","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2017.09.036_b0190","doi-asserted-by":"crossref","first-page":"e0131531","DOI":"10.1371\/journal.pone.0131531","article-title":"Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children","volume":"10","author":"Verschoor","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.09.036_b0195","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1099\/vir.0.067819-0","article-title":"Epitope mapping of the 2009 pandemic and the A\/Brisbane\/59\/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants","volume":"95","author":"Retamal","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.09.036_b0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CVI.00613-15","article-title":"Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories","volume":"23","author":"Zacour","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.09.036_b0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/irv.12411","article-title":"CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement","volume":"11","author":"Horby","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.09.036_b0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:29Z","timestamp":1778679089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17312653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":42,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17312653"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}